Deferoxamine vs Fluvastatin
Mechanistic comparison of Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as and Fluvastatin based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
4
Shared Targets
33%
Jaccard Similarity
25%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
Deferoxamine and Fluvastatin share 4 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.333 means 33% of the combined target set is bound by both compounds. The IDF-weighted score of 0.252 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.